CIK 0001802665
- Large accelerated filer
Harmony Biosciences Holdings, Inc.
Sign in to watch- Ticker
- HRMY
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 822279923
- Phone
- +1 484-539-9800
- Business address
- 630 W GERMANTOWN PIKE, SUITE 215, PLYMOUTH MEETING, PA, 19462
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $3,108,586
- in 2 filings
Net −$3,108,586. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-12-13 | Jacobs John C President, CEO | Sale | −13,140 | $38.02 | $500K | 11,860 |
| 2021-12-13 | Jacobs John C President, CEO | Sale | −11,860 | $38.43 | $456K | 0 |
| 2021-12-13 | Jacobs John C President, CEO | Exercise or conversion · Stock Option | −25,000 | 264,751 | ||
| 2021-12-10 | Wicki Andreas Director | Sale | −2,585 | $40.08 | $104K | 4,545,243 |
| 2021-12-08 | Wicki Andreas Director | Sale | −24,683 | $40.09 | $990K | 4,547,828 |
| 2021-11-18 | Szyper Linda M Director | Grant or award · Stock Option | +5,727 | 5,727 | ||
| 2021-11-17 | Wicki Andreas Director | Sale | −1,417 | $41.25 | $58K | 4,572,511 |
| 2021-11-16 | Wicki Andreas Director | Sale | −32,251 | $41.09 | $1.3M | 4,573,928 |
| 2021-11-15 | Wicki Andreas Director | Sale | −35,600 | $42.08 | $1.5M | 4,609,179 |
| 2021-11-01 | Dierks Jeffrey Chief Commercial Officer | Exercise or conversion | +10,000 | $8.22 | $82K | 10,000 |
| 2021-11-01 | Dierks Jeffrey Chief Commercial Officer | Sale | −7,054 | $41.36 | $292K | 2,946 |
| 2021-11-01 | Dierks Jeffrey Chief Commercial Officer | Sale | −2,946 | $42.44 | $125K | 0 |
| 2021-11-01 | Dierks Jeffrey Chief Commercial Officer | Exercise or conversion · Stock Option | −6,048 | 13,429 | ||
| 2021-11-01 | Dierks Jeffrey Chief Commercial Officer | Exercise or conversion · Stock Option | −3,952 | 19,476 | ||
| 2021-10-19 | Dayno Jeffrey M. Chief Medical Officer | Exercise or conversion | +14,099 | $8.22 | $116K | 14,099 |
| 2021-10-19 | Dayno Jeffrey M. Chief Medical Officer | Sale | −14,099 | $43.13 | $608K | 0 |
| 2021-10-19 | Dayno Jeffrey M. Chief Medical Officer | Exercise or conversion | +4,101 | $8.22 | $34K | 4,101 |
| 2021-10-19 | Dayno Jeffrey M. Chief Medical Officer | Sale | −4,101 | $43.77 | $180K | 0 |
| 2021-10-19 | Dayno Jeffrey M. Chief Medical Officer | Exercise or conversion · Stock Option | −14,099 | 57,570 | ||
| 2021-10-19 | Dayno Jeffrey M. Chief Medical Officer | Exercise or conversion · Stock Option | −4,101 | 53,469 |
Page 21 of 26 · 511 trades